Literature DB >> 30588378

Status epilepticus alert reduces time to administration of second-line antiseizure medications.

Mauricio F Villamar1, Aaron M Cook1, Chenlu Ke1, Yan Xu1, Jordan L Clay1, Katelyn S Dolbec1, Rachel Ward-Mitchell1, Larry B Goldstein1, Meriem Bensalem-Owen1.   

Abstract

BACKGROUND: Status epilepticus (SE) is a neurologic emergency with high morbidity and mortality. Delays in SE treatment are common in clinical practice and can be associated with poorer outcomes. Our goal was to determine whether the implementation of an SE alert protocol improves time to administration of a second-line antiseizure medication (ASM) in hospitalized adults.
METHODS: We developed and implemented an inpatient SE alert system. A quasiexperimental cohort study was performed. We analyzed all patients aged 18-85 years who were managed at the University of Kentucky Medical Center using the SE alert protocol between March 2015 and June 2017 (n = 19). Controls were the first 20 consecutive patients treated for SE over the same time period, but who were managed with usual care (i.e., without SE alert protocol).
RESULTS: Time to administration of a second-line ASM was shorter with the use of the SE alert system (22.21 ± 3.44 minutes) compared to usual care (58.30 ± 6.72 minutes; p < 0.0001).
CONCLUSION: Implementation of an SE alert system led to a marked improvement in time to administration of a second-line ASM. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for adult inpatients treated for SE, implementation of an SE alert protocol reduces time to administration of second-line ASM.

Entities:  

Year:  2018        PMID: 30588378      PMCID: PMC6294531          DOI: 10.1212/CPJ.0000000000000544

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  13 in total

1.  Predictors of functional disability and mortality after status epilepticus.

Authors:  J Claassen; J K Lokin; B-F M Fitzsimmons; F A Mendelsohn; S A Mayer
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

2.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors:  Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

3.  Association of seizure duration and outcome in refractory status epilepticus.

Authors:  Dominik Madžar; Anna Geyer; Ruben U Knappe; Stephanie Gollwitzer; Joji B Kuramatsu; Stefan T Gerner; Hajo M Hamer; Hagen B Huttner
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

4.  Time from convulsive status epilepticus onset to anticonvulsant administration in children.

Authors:  Iván Sánchez Fernández; Nicholas S Abend; Satish Agadi; Sookee An; Ravindra Arya; James Nicholas Brenton; Jessica L Carpenter; Kevin E Chapman; William D Gaillard; Tracy A Glauser; Howard P Goodkin; Kush Kapur; Mohamad A Mikati; Katrina Peariso; Margie Ream; James Riviello; Robert C Tasker; Tobias Loddenkemper
Journal:  Neurology       Date:  2015-05-06       Impact factor: 9.910

5.  Prognosis of status epilepticus (SE): Relationship between SE duration and subsequent development of epilepsy.

Authors:  E Santamarina; M Gonzalez; M Toledo; M Sueiras; L Guzman; N Rodríguez; M Quintana; G Mazuela; X Salas-Puig
Journal:  Epilepsy Behav       Date:  2015-06-25       Impact factor: 2.937

Review 6.  A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.

Authors:  Eugen Trinka; Hannah Cock; Dale Hesdorffer; Andrea O Rossetti; Ingrid E Scheffer; Shlomo Shinnar; Simon Shorvon; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2015-09-04       Impact factor: 5.864

7.  Analysis of the delay components in the treatment of status epilepticus.

Authors:  Leena Kämppi; Harri Mustonen; Seppo Soinila
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

8.  Time to treatment in prolonged seizure episodes.

Authors:  John M Pellock; Anthony Marmarou; Robert DeLorenzo
Journal:  Epilepsy Behav       Date:  2004-04       Impact factor: 2.937

9.  Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus.

Authors:  Leena Kämppi; Jaakko Ritvanen; Harri Mustonen; Seppo Soinila
Journal:  Epilepsy Res Treat       Date:  2015-08-10

10.  SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.

Authors:  Greg Ogrinc; Louise Davies; Daisy Goodman; Paul Batalden; Frank Davidoff; David Stevens
Journal:  BMJ Qual Saf       Date:  2015-09-14       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.